Publications

Anthracyclines Versus No Anthracyclines in the Neoadjuvant Strategy for Her2+Breast Cancer: Real-World Evidence

AuthID
P-00Y-SXB

Author(s)

de Pinho, IS

Luz, P

Alves, L

Lopes-Bras, R

Patel, V

Esperanca-Martins, M

Goncalves, L

Freitas, R

Simao, D

Galnares, MR

Fernandes, I

Criado, SA

Casado, SG

Canada, JB

Vega, IMS

Costa, JG

Fernandes, AS

de Sousa, RT

Costa, L

Document Type

Article in Press

Year published

2023

Published

in CLINICAL DRUG INVESTIGATION, ISSN: 1173-2563

Indexing

Wos^®

Scopus^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1007/s40261-023-01291-6

Pubmed: 37479867

Scopus: 2-s2.0-85165269029

Wos: WOS:001034278800001

Source Identifiers

ISSN: 1173-2563

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Anthracyclines Versus No Anthracyclines in the Neoadjuvant Strategy for Her2+Breast Cancer: Real-World Evidence

Useful Links

Get Help

Federated Authentication (Click on the image)

Anthracyclines Versus No Anthracyclines in the Neoadjuvant Strategy for Her2+Breast Cancer: Real-World Evidence

Useful Links

Get Help